These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 25187)

  • 21. A V kappa-J kappa junctional change in an antidigoxin recombinant antibody destroys digoxin-binding activity.
    Hudson NW; Bruccoleri RE; Steinrauf LK; Hamilton JA; Mudgett-Hunter M; Margolies MN
    J Immunol; 1990 Oct; 145(8):2718-24. PubMed ID: 2120338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the three-dimensional structures of a humanized and a chimeric Fab of an anti-gamma-interferon antibody.
    Fan ZC; Shan L; Goldsteen BZ; Guddat LW; Thakur A; Landolfi NF; Co MS; Vasquez M; Queen C; Ramsland PA; Edmundson AB
    J Mol Recognit; 1999; 12(1):19-32. PubMed ID: 10398393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identical VL region sequences of two antibodies from two outbred rabbits exhibiting complete idiotypic cross-reactivity and probably the same antigen-binding site fine structure.
    Brandt DC; Jaton JC
    J Immunol; 1978 Sep; 121(3):1194-8. PubMed ID: 151117
    [No Abstract]   [Full Text] [Related]  

  • 24. Conformations of the third hypervariable region in the VH domain of immunoglobulins.
    Morea V; Tramontano A; Rustici M; Chothia C; Lesk AM
    J Mol Biol; 1998 Jan; 275(2):269-94. PubMed ID: 9466909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hapten-induced allosteric transition in the light chain dimer of an immunoglobulin.
    Lancet D; Licht A; Schechter I; Pecht I
    Nature; 1977 Oct; 269(5631):827-9. PubMed ID: 412107
    [No Abstract]   [Full Text] [Related]  

  • 26. Photoaffinity probes in the antibody combining region.
    Richards FF; Lifter J
    Ann N Y Acad Sci; 1980; 346():78-89. PubMed ID: 6770738
    [No Abstract]   [Full Text] [Related]  

  • 27. Spectroscopic properties of light-chain derivatives of murine MOPC-315 immunoglobulin A.
    Zidovetzki R; Farver O; Pecht I
    Eur J Biochem; 1981; 114(1):97-100. PubMed ID: 6783405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Introduction of nucleophiles and spectroscopic probes into antibody combining sites.
    Pollack SJ; Nakayama GR; Schultz PG
    Science; 1988 Nov; 242(4881):1038-40. PubMed ID: 3194752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-V region framework antibodies affect the ligand binding of VL dimer.
    Ben-Neriah Y; Givol D; Gavish M
    Eur J Immunol; 1979 Jan; 9(1):91-3. PubMed ID: 108113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identical V region amino acid sequences and segments of sequences in antibodies of different specificities. Relative contributions of VH and VL genes, minigenes, and complementarity-determining regions to binding of antibody-combining sites.
    Kabat EA; Wu TT
    J Immunol; 1991 Sep; 147(5):1709-19. PubMed ID: 1908882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunochemical study of the conformational properties of the variable and constant domains of the light chain of mouse MOPC myeloma immunoglobulin].
    Petrosian MN; Vengerova TI; Rokhlin OV
    Mol Biol (Mosk); 1980; 14(5):1187-92. PubMed ID: 6158677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conformational flexibility of an antibody combining site composed of two identical V regions.
    Gavish M; Dwek RA; Givol D
    Eur J Immunol; 1978 Jan; 8(1):42-6. PubMed ID: 25187
    [No Abstract]   [Full Text] [Related]  

  • 33. Combining site and antigenic determinants of the V regions.
    Givol D; Gavish M; Zakut R; Ben-Neriah Y; Lonai P
    Haematologia (Budap); 1978-1979; 12(1-4):15-24. PubMed ID: 94027
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.